North America Syringe Infusion Pumps Market To Reach $1.04 Billion By 2030

North America Syringe Infusion Pumps Market Growth and Trends

The North America syringe infusion pumps market size is anticipated to reach USD 1.04 billion by 2030 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes.

The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by 2035.

Technological advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the market.

 Request a free sample copy or view report summary: North America Syringe Infusion Pumps Market Report

North America Syringe Infusion Pumps Market Report Highlights:

• Pediatrics/neonatology held the largest revenue share of over 25.0% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments

• The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period

• Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases.

• Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications.

• Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period.

• The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure.

North America Syringe Infusion Pumps Market Report Segmentation

Grand View Research has segmented the North America syringe infusion pumps market based on the disease indication, end use, and country:

North America Syringe Infusion Pumps Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Chemotherapy

• Diabetes

• Gastroenterology

• Analgesia/Pain management

• Pediatrics/Neonatology

• Hematology

• Others

North America Syringe Infusion Pumps End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Homecare

• Others (ASC, nursing homes, rehabilitation centers)

North America Syringe Infusion Pumps Country Outlook (Revenue, USD Million, 2018 - 2030)

• U.S.

• Canada

• Mexico

List of Key Players in the North America Syringe Infusion Pumps Market

• Baxter

• B. Braun Medical Inc.

• Fresenius Kabi AG

• ICU Medical, Inc.

• Micrel Medical Devices SA

• Boston Scientific Corporation

• BD

• Terumo Corporation

• Moog Inc.

• IRadimed Corporation

• CODAN Companies

• ACROMED